Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AlgometRx
Washington, District of Columbia, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
AlgometRx is developing the Nociometer, a handheld, non-invasive device and platform that analyzes pupil dilation in response to neuroselective stimulation to generate an objective nociceptive profile, characterizing pain type, intensity, and response to analgesics; the technology has proof-of-concept data across different pain populations and is being advanced with ARPA-H funding and collaborations with Children’s National Hospital, Johns Hopkins University, MedStar Research Institute, and Key Tech.[1][2][3][4]
- Therapeutic areas
- RheumatologyNeurology
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Physiological Monitoring
02
Partnerships
Children’s National Hospital[2][3][4]Key Technologies (Key Tech)[2]Johns Hopkins University[1]MedStar Research Institute[1]ARPA-H Sprint for Women’s Health (funding and development support)[1]
Beyond the preview
Go deeper on AlgometRx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AlgometRx.